Galactosylated cellulosic sponge for multi-well drug safety testing

Biomaterials

Volumn 32, Issue 29, 2011, Pages 6982-6994

  Nugraha, Bramasta ^a,b   Hong, Xin ^b,c   Mo, Xuejun ^b,d   Tan, Looling ^b   Zhang, Wenxia ^c   Chan, Po Mak ^b,c   Kang, Chiang Huen ^b   Wang, Yan ^b,e   Beng, Lu Thong ^c   Sun, Wanxin ^f   Choudhury, Deepak ^a,b   Robens, Jeffrey M ^h   McMillian, Michael ^g   Silva, Jose ^g   Dallas, Shannon ^g   Tan, Choon Hong ^d   Yue, Zhilian ^b   Yu, Hanry ^a,b,c,h,i,j  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

^f Bruker Corporation   (United States)

^g JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ SINGAPORE MIT ALLIANCE   (Singapore)

^j SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

more..

Author keywords

Cellulose; Cytochrome P450; Drug induction; Galactose; Hydrogel; Sponge

Indexed keywords

CELL MORPHOLOGY; CELL SEEDING; CELL-BASED ASSAYS; CELL-CELL INTERACTION; CYTOCHROME P450; DRUG ABSORPTION; DRUG INDUCTION; GALACTOSE; HEPATOCYTES; HIGH-THROUGHPUT; INNER CORE; MACROPOROUS; SPONGE;

CELL CULTURE; CELLS; HYDROGELS; SAFETY TESTING; THREE DIMENSIONAL;

SCAFFOLDS (BIOLOGY);

16ALPHA CYANOPREGNENOLONE; ALBUMIN; BETA NAPHTHOFLAVONE; CD147 ANTIGEN; CYTOCHROME P450 1A2; CYTOCHROME P450 2B2; CYTOCHROME P450 3A2; F ACTIN; GALACTOSYLATED CELLULOSIC SPONGE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTER 1; PHENOBARBITAL; TAUROCHOLIC ACID; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; UREA; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL POLARITY; CELL STRUCTURE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG SAFETY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPHEROID CELL; YOUNG MODULUS; ZETA POTENTIAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CELLULOSE; CYTOCHROME P-450 ENZYME SYSTEM; GALACTOSE; HEPATOCYTES; HIGH-THROUGHPUT SCREENING ASSAYS; HYDROGELS; MALE; MATERIALS TESTING; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; POROSITY; RATS; RATS, WISTAR; SPHEROIDS, CELLULAR; TISSUE ENGINEERING;

EID: 79960838651     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.087     Document Type: Article

References (52)

1. Smalley K.S., Lioni M., Herlyn M. Life isn't flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 2006, 42(8-9):242-247.
2. Griffith L.G., Swartz M.A. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 2006, 7(3):211-224.
3. Bartosh T.J., Ylostalo J.H., Mohammadipoor A., Bazhanov N., Coble K., Claypool K., et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A 2010, 107(31):13724-13729.
4. Fischbach C., Kong H.J., Hsiong S.X., Evangelista M.B., Yuen W., Mooney D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A 2009, 106(2):399-404.
5. Koide N., Sakaguchi K., Koide Y., Asano K., Kawaguchi M., Matsushima H., et al. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res 1990, 186(2):227-235.
6. Wang S., Nagrath D., Chen P.C., Berthiaume F., Yarmush M.L. Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng Part A 2008, 14(2):227-236.
7. Yuasa C., Tomita Y., Shono M., Ishimura K., Ichihara A. Importance of cell aggregation for expression of liver functions and regeneration demonstrated with primary cultured hepatocytes. J Cell Physiol 1993, 156(3):522-530.
8. Abu-Absi S.F., Friend J.R., Hansen L.K., Hu W.S. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 2002, 274(1):56-67.
9. Yamada T., Yoshikawa M., Kanda S., Kato Y., Nakajima Y., Ishizaka S., et al. In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 2002, 20(2):146-154.
10. Ivascu A., Kubbies M. Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 2006, 11(8):922-932.
11. Du Y., Chia S.M., Han R., Chang S., Tang H., Yu H. 3D hepatocyte monolayer on hybrid RGD/galactose substratum. Biomaterials 2006, 27(33):5669-5680.
12. Brophy C.M., Luebke-Wheeler J.L., Amiot B.P., Khan H., Remmel R.P., Rinaldo P., et al. Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 2009, 49(2):578-586.
13. Takahashi R., Sonoda H., Tabata Y., Hisada A. Formation of hepatocyte spheroids with structural polarity and functional bile canaliculi using nanopillar sheets. Tissue Eng Part A 2010, 16(6):1983-1995.
14. Nakazawa K., Izumi Y., Fukuda J., Yasuda T. Hepatocyte spheroid culture on a polydimethylsiloxane chip having microcavities. J Biomater Sci Polym Ed 2006, 17(8):859-873.
15. Yamashita Y., Shimada M., Tsujita E., Tanaka S., Ijima H., Nakazawa K., et al. Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver. Cell Transplant 2001, 10(8):717-722.
16. Ijima H., Nakazawa K., Koyama S., Kaneko M., Matsushita T., Gion T., et al. Development of a hybrid artificial liver using a polyurethane foam/hepatocyte-spheroid packed-bed module. Int J Artif Organs 2000, 23(6):389-397.
17. Lee J., Cuddihy M.J., Cater G.M., Kotov N.A. Engineering liver tissue spheroids with inverted colloidal crystal scaffolds. Biomaterials 2009, 30(27):4687-4694.
18. Wells R.G. The role of matrix stiffness in regulating cell behavior. Hepatology 2008, 47(4):1394-1400.
19. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol 1976, 13:29-83.
20. Zhang S., Tong W., Zheng B., Susanto T.A., Xia L., Zhang C., et al. A robust high-throughput sandwich cell-based drug screening platform. Biomaterials 2011, 32(4):1229-1241.
21. Yue Z., Wen F., Gao S., Ang M.Y., Pallathadka P.K., Liu L., et al. Preparation of three-dimensional interconnected macroporous cellulosic hydrogels for soft tissue engineering. Biomaterials 2010, 31(32):8141-8152.
22. Curcio E., Salerno S., Barbieri G., De Bartolo L., Drioli E., Bader A. Mass transfer and metabolic reactions in hepatocyte spheroids cultured in rotating wall gas-permeable membrane system. Biomaterials 2007, 28(36):5487-5497.
23. Tostoes R.M., Leite S.B., Miranda J.P., Sousa M., Wang D.I., Carrondo M.J., et al. Perfusion of 3D encapsulated hepatocytes-a synergistic effect enhancing long-term functionality in bioreactors. Biotechnol Bioeng 2011, 108(1):41-49.
24. Chang H.K., Park Y.J., Koh H., Kim S.M., Chung K.S., Oh J.T., et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr 2009, 49(3):323-328.
25. Wang M.H., Palmeri M.L., Guy C.D., Yang L., Hedlund L.W., Diehl A.M., et al. In vivo quantification of liver stiffness in a rat model of hepatic fibrosis with acoustic radiation force. Ultrasound Med Biol 2009, 35(10):1709-1721.
26. Luebke-Wheeler J.L., Nedredal G., Yee L., Amiot B.P., Nyberg S.L. E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transplant 2009, 18(12):1281-1287.
27. Harada K., Mitaka T., Miyamoto S., Sugimoto S., Ikeda S., Takeda H., et al. Rapid formation of hepatic organoid in collagen sponge by rat small hepatocytes and hepatic nonparenchymal cells. J Hepatol 2003, 39(5):716-723.
28. Talamini M.A., Kappus B., Hubbard A. Repolarization of hepatocytes in culture. Hepatology 1997, 25(1):167-172.
29. Ng S., Han R., Chang S., Ni J., Hunziker W., Goryachev A.B., et al. Improved hepatocyte excretory function by immediate presentation of polarity cues. Tissue Eng 2006, 12(8):2181-2191.
30. Sidler Pfandler M.A., Hochli M., Inderbitzin D., Meier P.J., Stieger B. Small hepatocytes in culture develop polarized transporter expression and differentiation. J Cell Sci 2004, 117(Pt 18):4077-4087.
31. Xia L., Ng S., Han R., Tuo X., Xiao G., Leo H.L., et al. Laminar-flow immediate-overlay hepatocyte sandwich perfusion system for drug hepatotoxicity testing. Biomaterials 2009, 30(30):5927-5936.
32. Nussler A.K., Wang A., Neuhaus P., Fischer J., Yuan J., Liu L., et al. The suitability of hepatocyte culture models to study various aspects of drug metabolism. ALTEX 2001, 18(2):91-101.
33. Sakai Y., Yamagami S., Nakazawa K. Comparative analysis of gene expression in rat liver tissue and monolayer- and spheroid-cultured hepatocytes. Cells Tissues Organs 2010, 191(4):281-288.
34. Wolkoff A.W., Cohen D.E. Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids. Am J Physiol Gastrointest Liver Physiol 2003, 284(2):G175-G179.
35. Pang K.S., Weiss M., Macheras P. Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts. Aaps J 2007, 9(2):E268-E283.
36. Dunn J.C., Tompkins R.G., Yarmush M.L. Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J Cell Biol 1992, 116(4):1043-1053.
37. Bokhari M., Carnachan R.J., Cameron N.R., Przyborski S.A. Novel cell culture device enabling three-dimensional cell growth and improved cell function. Biochem Biophys Res Commun 2007, 354(4):1095-1100.
38. Du Y., Han R., Wen F., Ng San San S., Xia L., Wohland T., et al. Synthetic sandwich culture of 3D hepatocyte monolayer. Biomaterials 2008, 29(3):290-301.
39. Zhang S., Xia L., Kang C.H., Xiao G., Ong S.M., Toh Y.C., et al. Microfabricated silicon nitride membranes for hepatocyte sandwich culture. Biomaterials 2008, 29(29):3993-4002.
40. Yin C., Liao K., Mao H.Q., Leong K.W., Zhuo R.X., Chan V. Adhesion contact dynamics of HepG2 cells on galactose-immobilized substrates. Biomaterials 2003, 24(5):837-850.
41. Hsiao C.C., Wu J.R., Wu F.J., Ko W.J., Remmel R.P., Hu W.S. Receding cytochrome P450 activity in disassembling hepatocyte spheroids. Tissue Eng 1999, 5(3):207-221.
42. Ranucci C.S., Kumar A., Batra S.P., Moghe P.V. Control of hepatocyte function on collagen foams: sizing matrix pores toward selective induction of 2-D and 3-D cellular morphogenesis. Biomaterials 2000, 21(8):783-793.
43. Kim M., Lee J.Y., Jones C.N., Revzin A., Tae G. Heparin-based hydrogel as a matrix for encapsulation and cultivation of primary hepatocytes. Biomaterials 2010, 31(13):3596-3603.
44. Green J.E., Waters S.L., Shakesheff K.M., Byrne H.M. A mathematical model of liver cell aggregation in vitro. Bull Math Biol 2009, 71(4):906-930.
45. Yoon J.J., Nam Y.S., Kim J.H., Park T.G. Surface immobilization of galactose onto aliphatic biodegradable polymers for hepatocyte culture. Biotechnol Bioeng 2002, 78(1):1-10.
46. Nyberg S.L., Hardin J., Amiot B., Argikar U.A., Remmel R.P., Rinaldo P. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl 2005, 11(8):901-910.
47. Seo S.J., Choi Y.J., Akaike T., Higuchi A., Cho C.S. Alginate/galactosylated chitosan/heparin scaffold as a new synthetic extracellular matrix for hepatocytes. Tissue Eng 2006, 12(1):33-44.
48. Chua K.N., Lim W.S., Zhang P., Lu H., Wen J., Ramakrishna S., et al. Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials 2005, 26(15):2537-2547.
49. Feng Z.Q., Chu X., Huang N.P., Wang T., Wang Y., Shi X., et al. The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function. Biomaterials 2009, 30(14):2753-2763.
50. Tzanakakis E.S., Waxman D.J., Hansen L.K., Remmel R.P., Hu W.S. Long-term enhancement of cytochrome P450 2B1/2 expression in rat hepatocyte spheroids through adenovirus-mediated gene transfer. Cell Biol Toxicol 2002, 18(1):13-27.
51. Padgham C.R., Paine A.J., Phillips I.R., Shephard E.A. Maintenance of total cytochrome P-450 content in rat hepatocyte culture and the abundance of CYP1A2 and CYP2B1/2 mRNAs. Biochem J 1992, 285:929-932.
52. Budinsky R.A., LeCluyse E.L., Ferguson S.S., Rowlands J.C., Simon T. Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8-pentachlorodibenzofuran. Toxicol Sci 2010, 118(1):224-235.